JPRN-UMIN000012221招募中未知
Treatment with aflibercept for AMD cases with better value in optometry - Treatment with aflibercept for AMD cases with better value in optometry (TAABO study)
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Prior treatment with triamcinolone (<3 montsh 2)Prior treatment with dexamethasone <30 days) 3)Prior intraocular surgery (<3 months) 4)Prior vitrectomy 5)Hypersensitivity or allergy to fluorescein or indocyanine green, clinically significant drug allergy or known hypersensitivity to therapeutic or diagnostic protein products 6)Patient with pregnancy or its possibility, and with breast-feeding 7)Patient who the doctor in charge judges are ineligible for the study
研究者
相似试验
未知
不适用
Aflibercept treat and extend for macular edema secondary to branch retinal vein occlusiobranch retinal vein occlusionJPRN-UMIN000027100Jikei daisan hospital50
已完成
2 期
Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung AdenocarcinomaPulmonary DiseasesNeoplasms, LungNCT00284141Sanofi98
招募中
4 期
Prospective study evaluating aflibercept in patients with recurrent or prolonged diabetic macular edema after vitrectomyDiabetic macular edemaJPRN-UMIN000016036Kyushu university30
已完成
不适用
Investigation of clinical efficacy of aflicbercept in patients with polypoidal choroidal vasculopathy (PCV) with resistance of ranibizumabPolypoidal choroidal vasculopathyJPRN-UMIN000012493Department of Ophthalmology, Graduate School of Medicine, The University of Tokyo30
已完成
不适用
Investigation of clinical efficacy for Aflibercept in patients with polypoidal choroidal vasculopathy (PCV)Polypoidal Choroidal VasculopathyJPRN-UMIN000011091Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University50